login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
AADI BIOSCIENCE INC (AADI) Stock News
USA
-
Nasdaq
- NASDAQ:AADI -
US00032Q1040
-
Common Stock
2.05
USD
-0.05 (-2.38%)
Last: 3/18/2025, 8:20:08 PM
2.06
USD
+0.01 (+0.49%)
After Hours:
3/18/2025, 8:20:08 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
AADI Latest News, Press Relases and Analysis
All
Press Releases
9 months ago - By: Aadi Bioscience
Aadi Bioscience to Report Fourth Quarter and Full-Year 2024 Results and Corporate Update
9 months ago - By: Aadi Bioscience
Aadi Bioscience Announces Closing of $100 Million PIPE Financing
10 months ago - By: Aadi Bioscience
Aadi Bioscience Announces Approval of All Proposals at Special Meeting of Stockholders
10 months ago - By: Aadi Bioscience
Aadi Bioscience to Present at the TD Cowen 45th Annual Healthcare Conference
10 months ago - By: Aadi Bioscience
Aadi Bioscience Filed Definitive Proxy Statement and Schedules Special Meeting of Stockholders for February 28, 2025
a year ago - By: Benzinga
Why Is Cancer-Focused Aadi Bioscience Stock Trading Higher On Friday?
2 years ago - By: Benzinga
Aadi Bioscience Earnings Preview
a year ago - By: Aadi Bioscience
Aadi Bioscience Transforms with In-Licensing of Novel ADC Portfolio, $100 Million Sale of FYARRO® and $100 Million PIPE Financing
a year ago - By: Aadi Bioscience
Aadi Bioscience Announces Financial Results for the Third Quarter 2024 and Provides Corporate Update
a year ago - By: Aadi Bioscience
Aadi Bioscience to Report Third Quarter 2024 Results and Corporate Update
a year ago - By: Aadi Bioscience
Aadi Bioscience Provides PRECISION1 Trial and Corporate Updates
a year ago - By: Aadi Bioscience
Aadi Bioscience Announces Financial Results for the Second Quarter 2024 and Provides Corporate Update
a year ago - By: Aadi Bioscience
Aadi Bioscience to Report Second Quarter 2024 Results and Corporate Update
a year ago - By: BusinessInsider
3 Russell 2000 Stocks to Sell in July Before They Crash & Burn
a year ago - By: InvestorPlace
- Mentions:
AAOI
BCAL
3 Russell 2000 Stocks to Sell in July Before They Crash & Burn
2 years ago - By: Aadi Bioscience
Aadi Bioscience to Participate in the Jefferies Healthcare Conference
2 years ago - By: Aadi Bioscience
Aadi Bioscience Presents New Nonclinical Data Demonstrating Preferential Tumor Uptake of nab-Sirolimus at the American Society of Clinical Oncology (ASCO) Annual Meeting
2 years ago - By: InvestorPlace
AADI Stock Earnings: Aadi Bioscience Misses EPS, Misses Revenue for Q1 2024
2 years ago - By: Aadi Bioscience
Aadi Bioscience Announces Financial Results for the First Quarter 2024 and Provides Corporate Update
2 years ago - By: Aadi Bioscience
Aadi Bioscience to Report First Quarter 2024 Results and Corporate Update
2 years ago - By: Aadi Bioscience
Aadi Bioscience Presents New Subgroup Analysis of Patients with Advanced Malignant PEComa of Gynecologic Origin Treated with nab-Sirolimus at Society of Gynecologic Oncology (SGO)
2 years ago - By: Aadi Bioscience
Aadi Bioscience Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Corporate Update
2 years ago - By: Aadi Bioscience
Aadi Bioscience to Report Fourth Quarter and Full-Year 2023 Results and Corporate Update
2 years ago - By: Aadi Bioscience
Aadi Bioscience to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024
2 years ago - By: Aadi Bioscience
Aadi Bioscience Announces Publication of Long-Term Efficacy and Safety Data Further Supporting FYARRO® for the Treatment of Malignant PEComa
2 years ago - By: Aadi Bioscience
Aadi Bioscience to Present at the TD Cowen 44th Annual Healthcare Conference
2 years ago - By: Seeking Alpha
Aadi Bioscience files for $150M mixed shelf (NASDAQ:AADI)
2 years ago - By: Aadi Bioscience
Aadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium
2 years ago - By: Aadi Bioscience
Aadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium
Please enable JavaScript to continue using this application.